OnKure Therapeutics, Inc. (OKUR) stock
OKURNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.58−0.17 (-6.18%)
Close on Nov 17, 2026Market cap $104.48MP/E –Yield –
OnKure Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
OnKure Therapeutics's enterprise value was -$100.23M on Nov 11, 2026, against -$37.05M a year earlier. Over the last 5 years it ranged from -$140.24M to $159.64M, with a median of -$49.40M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$100.23M | – |
| 2025 | Dec 31, 2025 | -$38.27M | – |
| 2024 | Dec 31, 2024 | -$47.95M | – |
| 2023 | Dec 29, 2023 | -$71.42M | – |
| 2022 | Dec 30, 2022 | -$58.93M | -215.6% |
| 2021 | Dec 31, 2021 | $50.95M | – |
See a number that looks wrong?